Active substance
Carmellose
- SFDA 4
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| REFRESH LIQUIGEL 1% EYE DROPS | 1 % | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 15.80 | NCE · OTC | AbbVie Inc | Valid |
| REFRESH TEARS 0.5% EYE DROPS | 0.5 % | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 15.80 | NCE · OTC | AbbVie Inc | Valid |
| CELLUVISC 1% EYE DROPS | 1 % | Eye drops · Ophthalmic use | 30 Dropper Container | SAR 15.75 | NCE · OTC | ALLERGAN PHARMACEUTICALS LTD | Withdrawn by MAH · Not Marketed |
| REFRESH PLUS | 0.5 % | Eye drops, solution · Ophthalmic use | 30 Dropper Container | SAR 20.10 | NCE · OTC | AbbVie Inc | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); ANESTHESIA-SUPPORTIVE AGENTS/ EYE DRYNESS IN PATIENTS RECEIVING CONTINUOUS INFUSIONS OF NEUROMUSCULAR BLOCKERS.; OCULAR ROSACEA; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Carmellose 0.5% eye drops 0.4ml unit dose preservative free | £4.80 | 30 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Carmellose 1% eye drops 0.4ml unit dose preservative free | £3.00 | 30 unit dose | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.